|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Chan BK, Wiseberg-Firtell JA, Jois RH,
Jensen K and Audisio RA: Localization techniques for guided
surgical excision of non-palpable breast lesions. Cochrane Database
Syst Rev. (CD009206)2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Sharma R, Sharma R, Khaket TP, Dutta C,
Chakraborty B and Mukherjee TK: Breast cancer metastasis: Putative
therapeutic role of vascular cell adhesion molecule-1. Cell Oncol
(Dordr). 40:199–208. 2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Liu L, Zhang Y, Wong CC, Zhang J, Dong Y,
Li X, Kang W, Chan FKL, Sung JJY and Yu J: RNF6 promotes colorectal
cancer by activating the Wnt/β-catenin pathway via ubiquitination
of TLE3. Cancer Res. 78:1958–1971. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Liang Q, Ma D, Zhu X, Wang Z, Sun TT, Shen
C, Yan T, Tian X, Yu T, Guo F, et al: RING-finger protein 6
amplification activates JAK/STAT3 pathway by modifying SHP-1
ubiquitylation and associates with poor outcome in colorectal
cancer. Clin Cancer Res. 24:1473–1485. 2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Cai J, Xiong Q, Jiang X, Zhou S and Liu T:
RNF6 facilitates metastasis and radioresistance in hepatocellular
carcinoma through ubiquitination of FoxA1. Exp Cell Res.
374:152–161. 2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Xu K, Shimelis H, Linn DE, Jiang R, Yang
X, Sun F, Guo Z, Chen H, Li W, Chen H, et al: Regulation of
androgen receptor transcriptional activity and specificity by
RNF6-induced ubiquitination. Cancer Cell. 15:270–282.
2009.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lo HS, Hu N, Gere S, Lu N, Su H, Goldstein
AM, Taylor PR and Lee MP: Identification of somatic mutations of
the RNF6 gene in human esophageal squamous cell carcinoma. Cancer
Res. 62:4191–4193. 2002.PubMed/NCBI
|
|
9
|
Qin X, Chen S, Qiu Z, Zhang Y and Qiu F:
Proteomic analysis of ubiquitination-associated proteins in a
cisplatin-resistant human lung adenocarcinoma cell line. Int J Mol
Med. 29:791–800. 2012.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Hippo signaling mediates ferroptosis in
malignant mesothelioma. Cancer Discov. 9(1155)2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Turunen SP, von Nandelstadh P, Öhman T,
Gucciardo E, Seashore-Ludlow B, Martins B, Rantanen V, Li H,
Höpfner K, Östling P, et al: FGFR4 phosphorylates MST1 to confer
breast cancer cells resistance to MST1/2-dependent apoptosis. Cell
Death Differ. 26:2577–2593. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Gomez M, Kulaberoglu Y and Hergovich A:
MST1/2 kinase assays using recombinant proteins. Methods Mol Biol.
1893:319–331. 2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ji XY, Zhong G and Zhao B: Molecular
mechanisms of the mammalian Hippo signaling pathway. Yi Chuan.
39:546–567. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
He L, Yuan L, Sun Y, Wang P, Zhang H, Feng
X, Wang Z, Zhang W, Yang C, Zeng YA, et al: Glucocorticoid receptor
signaling activates TEAD4 to promote breast cancer progression.
Cancer Res. 79:4399–4411. 2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Tang DE, Dai Y, Lin LW, Xu Y, Liu DZ, Hong
XP, Jiang HW and Xu SH: STUB1 suppresseses tumorigenesis and
chemoresistance through antagonizing YAP1 signaling. Cancer Sci.
110:3145–3156. 2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Chen M, Zhang H, Shi Z, Li Y, Zhang X, Gao
Z, Zhou L, Ma J, Xu Q, Guan J, et al: The MST4-MOB4 complex
disrupts the MST1-MOB1 complex in the Hippo-YAP pathway and plays a
pro-oncogenic role in pancreatic cancer. J Biol Chem.
293:14455–14469. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Dent P, Booth L, Roberts JL, Liu J,
Poklepovic A, Lalani AS, Tuveson D, Martinez J and Hancock JF:
Neratinib inhibits Hippo/YAP signaling, reduces mutant K-RAS
expression, and kills pancreatic and blood cancer cells. Oncogene.
38:5890–5904. 2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Lipkowitz S and Weissman AM: RINGs of good
and evil: Ring finger ubiquitin ligases at the crossroads of tumour
suppression and oncogenesis. Nat Rev Cancer. 11:629–643.
2011.PubMed/NCBI View
Article : Google Scholar
|
|
19
|
Fang S, Lorick KL, Jensen JP and Weissman
AM: Ring finger ubiquitin protein ligases: Implications for
tumorigenesis, metastasis and for molecular targets in cancer.
Semin Cancer Biol. 13:5–14. 2003.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Zhu L, Tong G, Chen J, Wang Y, Wang S,
Zhao M, Li J and Ma J: Cloning and identification of a novel RNF6
transcriptional splice variant Spg2 in human development. Sci China
C Life Sci. 51:302–307. 2008.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Viale G, Hanlon Newell AE, Walker E,
Harlow G, Bai I, Russo L, Dell'Orto P and Maisonneuve P: Ki-67
(30-9) scoring and differentiation of Luminal A- and Luminal B-like
breast cancer subtypes. Breast Cancer Res Treat. 178:451–458.
2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Chen JY, Lai YS, Chu PY, Chan SH, Wang LH
and Hung WC: Cancer-derived VEGF-C increases chemokine production
in lymphatic endothelial cells to promote CXCR2-dependent cancer
invasion and MDSC recruitment. Cancers (Basel).
11(1120)2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Paoletti C, Miao J, Dolce EM, Darga EP,
Repollet MI, Doyle GV, Gralow JR, Hortobagyi GN, Smerage JB, Barlow
WE and Hayes DF: Circulating tumor cell clusters in metastatic
breast cancer patients: A SWOG S0500 translational medicine study.
Clin Cancer Res. 25(0208.2019)2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
D'Agostino L, Nie Y, Goswami S, Tong K, Yu
S, Bandyopadhyay S, Flores J, Zhang X, Balasubramanian I, Joseph I,
et al: Recycling endosomes in mature epithelia restrain tumorigenic
signaling. Cancer Res. 79:4099–4112. 2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Salah Z, Melino G and Aqeilan RI:
Correction: Negative regulation of the Hippo pathway by E3
ubiquitin ligase ITCH is sufficient to promote tumorigenicity.
Cancer Res. 79(3007)2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Pan Z, Tian Y, Cao C and Niu G: The
emerging role of YAP/TAZ in tumor immunity. Mol Cancer Res.
17:1777–1786. 2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wu J, Minikes AM, Gao M, Bian H, Li Y,
Stockwell BR, Chen ZN and Jiang X: Intercellular interaction
dictates cancer cell ferroptosis via NF2-YAP signalling. Nature.
572:402–406. 2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Gobbi G, Donati B, Do Valle IF, Reggiani
F, Torricelli F, Remondini D, Castellani G, Ambrosetti DC,
Ciarrocchi A and Sancisi V: The Hippo pathway modulates resistance
to BET proteins inhibitors in lung cancer cells. Oncogene.
38:6801–6817. 2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Huang W, Hu H, Zhang Q, Wu X, Wei F, Yang
F, Gan L, Wang N, Yang X and Guo AY: Regulatory networks in
mechanotransduction reveal key genes in promoting cancer cell
stemness and proliferation. Oncogene. 38:6818–6834. 2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Li JA, Kuang T, Pu N, Fang Y, Han X, Zhang
L, Xu X, Wu W, Wang D, Lou W and Rong Y: TRAF6 regulates YAP
signaling by promoting the ubiquitination and degradation of MST1
in pancreatic cancer. Clin Exp Med. 19:211–218. 2019.PubMed/NCBI View Article : Google Scholar
|
